Financial results: Avecho; Elixinol; Epsilon; Creso Pharma by Steve Jones May 2, 2023April 30, 2024 Biotech firm Avecho has told the Australian Securities Exchange (ASX) that it has no concerns over […]
Bod’s S3 registration candidate to go on sale through Special Access Scheme by Steve Jones June 27, 2022April 29, 2024
Patience the watchword as companies line up to put S3 visions to the test by Steve Jones March 30, 2021April 26, 2024
Cann Group eyes S3 product and the end of ‘unsophisticated’ formulations by Steve Jones February 18, 2021April 26, 2024
Drop SAS for CBD prescriptions, GP urges, as industry calls for low dose re-think by Steve Jones November 5, 2020April 26, 2024
Major doubts remain as industry reacts to CBD down scheduling by Steve Jones September 10, 2020April 22, 2024
Warning over CBD ‘red herring’ amid concerns about TGA demands by Steve Jones July 15, 2020August 5, 2020
